Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Allergan discloses compounds with retinoid-like activity

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Divestment of antimigraine treatment from Glaxo Wellcome to Zeneca

Sep. 13, 1996

Retinoid compounds for dermatological disorders

Sep. 13, 1996

Controlled-release oral analgesic formulation claimed by Euroceltique

Sep. 13, 1996

Chiron describes a new opiate receptor ligand

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...